{"id":4364,"date":"2024-07-11T09:42:25","date_gmt":"2024-07-11T13:42:25","guid":{"rendered":"https:\/\/sjogren.ca\/research\/"},"modified":"2024-08-03T17:34:53","modified_gmt":"2024-08-03T21:34:53","slug":"research","status":"publish","type":"page","link":"https:\/\/sjogren.ca\/en\/research\/","title":{"rendered":"Research"},"content":{"rendered":"\n\n\t

Recherche clinique Qu\u00e9bec: a new provincial resource for clinical research<\/strong><\/h3>\n

Medical research: the hidden face of the healthcare system. Like an iceberg, underneath the visible part of our healthcare system lies a medical research ecosystem in which numerous scientists, ethics committees and clinical research specialists work. Although still little-known, the medical research ecosystem is essential: it enables the development and improvement of all treatments offered to the population, and the analysis of their efficacy and safety.<\/p>\n

R\u00e9seau Catalis is rolling out a new 2024-2028 strategic plan in collaboration with its partners, the Minist\u00e8re de la Sant\u00e9 et des Services sociaux (MSSS) and the Minist\u00e8re de l’\u00c9conomie, de l’Innovation et de l’\u00c9nergie (MEIE). For more information…<\/strong><\/a><\/p>\n

Clinical research is based on results obtained in the laboratory during the following stages: basic research and preclinical research. It seeks to prove the efficacy and safety of potential new treatments in humans, notably through clinical trials. Depending on the innovation under study, clinical trials are carried out with the participation of healthy people or people with a specific medical condition. Clinical trials are an essential step in the development of all innovative treatments that benefit the public. Clinical research falls into two broad categories: observational studies and interventional clinical trials. Both are conducted on human subjects. For more information…<\/strong><\/a><\/p>\n

More than 100,000 clinical trials are currently being conducted worldwide, including over 2,300 in Quebec. These trials are conducted in over 23 affiliated public health and social service establishments (hospitals, clinics and local community service centers [CLSCs]) by more than 675 researchers.<\/p>\n

The active participation of patients is essential in clinical research. It enables the development of medical innovations that improve the quality of life of the entire population. Participating in a clinical trial can help advance research, propel innovation in healthcare and, in the longer term, provide better treatment options for the entire population. To more information…<\/b><\/a><\/p>\n

\n

Study description <\/strong>\u00a0–\u00a0\u00a01 center<\/h3>\n

Study summary<\/strong><\/h3>\n

L’objectif de l’\u00e9tude est d’\u00e9valuer l’efficacit\u00e9 de l’ianalumab (\u00e9galement appel\u00e9 VAY736) chez les personnes atteintes d’un syndrome de Sj\u00f6gren actif. \u00c9tant donn\u00e9 qu’aucun traitement syst\u00e9mique n’est approuv\u00e9 pour le syndrome de Sj\u00f6gren, cette \u00e9tude permettra de comparer l’ianalumab et un placebo, c’est-\u00e0-dire une substance qui ressemble \u00e0 un m\u00e9dicament, mais qui n’exerce aucun effet th\u00e9rapeutique.(FAST TRACK) NEPTUNUS-2 – Une \u00e9tude de phase 3 multicentrique \u00e0 trois bras, randomis\u00e9e, en double aveugle, contr\u00f4l\u00e9e par placebo pour \u00e9valuer l’efficacit\u00e9 et la s\u00e9curit\u00e9 de l’ianalumab chez les patients atteints du syndrome de sj\u00f6gren actif (neptunus-2).<\/p>\n

M\u00e9dicament exp\u00e9rimental – Phase III<\/p>\n

CRIT\u00c8RES DE S\u00c9LECTION<\/strong><\/p>\n

Crit\u00e8res d’inclusion<\/em><\/p>\n